New NIH R01 Funded

Associate Elizabeth (Beth) Sharlow, Associate Director of the Fiske Drug Discovery Laboratory, has just received a $1.2 million R01 grant from the NIH to develop a precision high content screening assay for Abeta-mediated neuronal cell cycle re-entry. This grant builds on funding to the Fiske Drug Discovery Laboratory from the Cure Alzheimer’s Fund and the Owen Family Foundation.